Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 7 of the 13 calendar months from Oct 2025 to Oct 2026: Mar 2026, Apr 2026, May 2026, Jun 2026, Jul 2026, Aug 2026 and Sep 2026.
- Largest single sale: $156K (1,700 shares) of Dexcom on Aug 14, 2026. Filing
- Last sale before this period: Aug 15, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Dexcom (DXCM) | EVP Chief Legal Compliance Off | Mar 10, 2022 | Sep 16, 2026 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Sep 15, 2026, Dexcom: sold 1,700 shares for $143K, under a disclosed plan. 1 filing: 1
- Aug 22, 2026, Dexcom: 1,451 shares withheld by the company for taxes. 1 filing: 1
- Aug 14, 2026, Dexcom: sold 1,700 shares for $156K, under a disclosed plan. 1 filing: 1
- Jul 15, 2026, Dexcom: sold 1,700 shares for $127K, under a disclosed plan. 1 filing: 1
- Jun 15, 2026, Dexcom: sold 1,700 shares for $128K, under a disclosed plan. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.